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Abstract
Background: Bisphenol A (BPA) is an environmental compounds is known to possess endocrine disruption potentials.
Bisphenol A has epigenetic effects as deregulated expression of microRNAs; such epigenetic marks can induce up/down
alterations in gene expression that may persist throughout a lifetime. Bisphenol A (BPA) exposure has been documented
in pregnant women, but consequences for development of offspring after BPA exposure during pregnancy are not yet
widely studied. Therefore, the aim of this study was to gain a comprehensive understanding of microRNAs changes in
the placenta transcriptome from pregnant women subjected to therapeutic abortion for fetal malformation and correlate
the impact of gestational exposure to BPA on these developmental changes.
Methods: We performed a comparative analysis of genome wide miRNA expression in placentas from pregnant women
exposed to BPA using microarray technology to identify miRNAs which were aberrantly expressed in placentas from
malformed fetuses. The expression changes of differential expressed miRNAs in the samples used for microarray were
confirmed by qPCR . Beside, we applied various bioinformatics tools to predict the target genes of the identified
miR-146a and explore their biological function and downstream pathways.
Results: We found that miR-146a was significant overexpressed and correlated significantly with BPA accumulation
in the placenta from pregnant women living in a polluted area and undergoing therapeutic abortion due to fetal
malformations. Beside, we applied various bioinformatics tools to predict the target genes of miR-146a and explore their
biological function and downstream pathways.
Conclusions: For the first time, we found, in humans, that miR-146a was significant over-expressed and correlated
significantly with BPA accumulation in the placenta. Our results lead to the suggestion that miRNAs could be potential
biomarkers to clarify the mechanisms of environmental diseases.
Background
Bisphenol A is produced in high volume worldwide for use
in a variety of industrial and consumer products. Exposure
to BPA at concentrations detected in humans has been re-
ported to affect neurological, cardiovascular and metabolic
diseases (such as diabetes), and even cancers [1]. Low level
BPA exposure may impact placental tissue development and
function in humans. For its toxicity and estrogenic activity,
BPA is a potential concern to fetal and infant health end-
points since has been found in a variety of human tissues
and body fluids as follicular and amniotic fluid [2], umbilical
cord blood and placental tissue [3], and breast milk [4].
Recent data from in vitro studies suggest that fetal
exposure to BPA can occur throughout placental exchange
[5] and that BPA exposure at doses (0.02 - 0.1 μg/mL) close
to those found in some pregnant women can induce cell
death in isolated human cytotrophoblast cells [6].
It is known that prenatal exposure to BPA has irreversible
effects on prenatal reproductive development [7, 8]; and
was associated with a significant increase in the birth
weight of male infants [7]. Beside, effects on anthropomet-
ric measures at 4 years of age [9] adipokine levels in 9-year-
old children [10], child wheeze [11] and child behaviour
[12], and obesity in school-age children. The perinatal
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period corresponds to the temporal window when the en-
amel of the permanent incisors and first molars is being
formed. BPA may be involved in molar incisor hypo-
mineralization (MIH) by having an adverse effect on amelo-
genesis [2].
BPA, as endocrine disruptor may be one of the many crit-
ical factors in aberrant development of external genitalia
that manifests as hypospadias [13].
Ambient air pollution is associated with birth weight and
preterm birth and health outcomes of maternal BPA expos-
ure are fetal toxicity, impairing fetal growth and associated
with prenatal and postnatal side effects [14, 15]. In mouse
prenatal exposure to bisphenol A affects adult murine neo-
cortical development and thalamocortical connections [16]
and disrupts the normal function of the reproductive axis
in prepuberal male rats [17], The effects of the BPA may be
exerted at different levels of the axis and may be dependent
on the dose, manner of administration, and the moment of
exposure to the disruptor.
Prenatal exposure to low doses of bisphenol A (BPA)
may cause epigenetic changes as histone modifications,
DNA hypermethylation/hypomethylation at CpG islands
near gene promoter regions, and deregulated expression
of non-coding RNAs, including microRNAs. These epi-
genetic marks can induce up/down alterations in gene
expression that may persist throughout a lifetime resulting
in adverse health effects such as infertility, neural and
immune disorders, and late-onset complex diseases as
cancers and diabetes.
MicroRNAs (miRNAs) are approximately 22 nucleotide
long non-coding RNAs capable of regulating gene expres-
sion post-transcriptionally through imperfect complemen-
tarity with a target mRNA, and are considered a mode of
epigenetic regulation [18].
Aberrant miRNA expression has been implicated in a
several cellular processes and pathogenic pathways of a
number of diseases [19, 20]. Evidence is rapidly growing
that miRNA regulation of gene expression may be affected
by environmental chemicals [21, 22]. The accumulating
evidence linking miRNAs to environmental chemicals,
coupled with the unique regulatory role of miRNAs in
gene expression, makes microRNAs potential biomarkers
for better understanding the mechanisms of environmen-
tal diseases.
The exact mechanisms by which the environmental
factors alter miRNAs expression are not completely
understood. A conceptual model that may help explain
the mechanism underlying miRNAs dysregulation
induced by environmental chemicals is centred on
‘inflammation and oxidative stress, having a direct
impact on miRNAs deregulation. However, this model
may be limited to those environmental chemicals for
which inflammation and oxidative stress are primary
mediators of toxicity.
Therefore, it has been assumed that chemicals in the en-
vironment might cause miRNAs deregulation by increasing
the oxidative stress and / or the activation of inflammatory
responses. Indeed, both processes are implicated in various
diseases [21].
Regarding miRNAs, it has been shown that BPA expos-
ure of human placental cell lines can alter miRNA expres-
sion levels, and in particular, hsa-miR-146a was strongly
induced by BPA treatment. This resulted in both slower
proliferation rate and higher sensitivity to the DNA
damaging agent bleomycin [23]. TM4 mouse sertoli cell
line exposed to BPA for 24 h was reported to have two-fold
up or down-regulated 37 miRNAs, and most of miRNAs
were down-regulated over the course of BPA treatment
[24]. Placenta is able to accumulate BPA, as well as transfer
BPA to the fetus, which has little capacity to deactivate
BPA. Since placenta is generally discarded after delivery,
such tissue is ideal to use for biomonitoring of potential
toxicants. Placental delivery takes place after the birth of
the child, so it is a non-invasive, long-term sample that can
be analyzed for the passage of toxicants into the fetus [25].
In the present study, we performed a comparative ana-
lysis of genome wide miRNA expression in placentas from
pregnant women exposed to BPA using microarray tech-
nology to identify miRNAs that were aberrantly expressed
in placentas from malformed fetuses. We found that miR-
146a was significant over-expressed and correlated to BPA
accumulation in the placenta as a measure of fetal exposure
related to fetal malformations. In addition, we applied vari-
ous bioinformatics tools to predict the target genes of the
identified miR-146a and explore their biological function
and downstream pathways.
Results
Forty placenta samples from pregnant women living in a
polluted area (patient group subjected to therapeutic
abortion occurring in the second trimester of pregnancy
for fetal malformation) and 40 placenta samples from
pregnant women living in a non-polluted area (control
group: women with a healthy pregnancy) were used for
genome-wide miRNA expression profiling.
Subject characteristics and exposure
The characteristics of the 80 study subjects are summarized
in Table 1. Maternal age, gestational age, body mass index,
and gender ratio of the fetuses did not differ between
malformed and normal fetuses (P > 0.05 for all, Table 1).
Microarray analysis
In this study, 1349 miRNAs including 1205 human
miRNAs and 144 human viral miRNAs were profiled.
We dentified differentially expressed miRNAs in pla-
centa samples according to the presence or absence of
malformed fetuses. Thirty-four miRNAs had at least a
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2.5-fold difference in expression at P < 0.05/ Twelve
miRNAs were up-regulated and six miRNAs were
down-regulated in placentas samples from malformed
fetuses (Table 2). The expression changes of differential
expressed miRNAs in the samples used for microarray
were confirmed by qPCR. Specifically, miR-146a was
strongly induced.
Differences in miR-146a expression between patients and
control group
miR-146a expression was significantly increased in placenta
samples taken from pregnant women whose fetuses had
malformations compared with women with a healthy preg-
nancy (p < 0.05; Fig. 1a).
BPA analysis
The BPA exposure has been studied on a subset of the
enrolled women (40 patients and 40 controls). BPA was
significant absent in the control group, while were de-
tected only in the patients subjected to therapeutically
abortion (Fig. 1b). High level of BPA was associated with a
significant increased miR-146a expression. Figure 2 shows
the positive correlation between BPA level and miR-146a
relative expression in placentas from pregnant women liv-
ing in polluted area (r = 0. 9789) (p < 0.05).
Target mapping and functional analysis: potential
interactions of miR-146a
To explore the functional significance of the miRNAs in-
vestigated, we applied KEGG (www.genome.jp/kegg/), a
pathway analysis database, to the target genes identified for
miR-146a using miRanda and TargetScan. The enriched
pathways we identified appeared to be largely overlapping,
since many target genes were in more than one pathway.
Among the top-ranked pathways, we found those related to
general functions (e.g., enzymes, cell cycle) and others with
more specific functions, including a high proportion of
pathways related to signal transduction, transcription fac-
tors, cancer and nervous system-related genes.
Identifying targets can facilitate elucidation of the role
of miR-146a in BPA exposure. Usually, one miRNA has
hundreds of target genes, and a group of miRNAs co-
modulated a signalling pathway. MiR-146a target genes
were obtained from the databases mentioned above.
Subsequently, these target genes were mapped to KEGG,
to identify molecular function, signalling pathways and
their cell location.
There were 19 significant (p < 0.01) biological func-
tions associated with miR146a target genes under BPA
Table 1 Biological characteristics of the study population
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Trisomy 21 6 (20)
Nervous system diseases 13 (26,7)
Other 5 (16,6)
Cardiac malformation 14 (30)
Hydrops fetalis 2 (6,7)
Table 2 List of significantly dysregulated miRNAs from
placentas after BPA exposure
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exposure (Fig. 3). One of these functions described
neural disease genes pathway, which was the second
most significant function on the list (p = 0.002) and com-
prised 12 genes: IRAK1, MYT1, ROBO1, LRRTM2,
GRID1, SORT1, BCL11A, SYT1, NPAS4,MLL2, DNAL1,
EDNRB. Such genes were involved in differentiation and
proliferation of sympathetic neuron, communication dis-
orders, import of L-glutamic acid, outgrowth of sensory
axons, brain-derived neurotrophic factor, damage of hip-
pocampal cells.
Fig. 1 MiR-146a expression levels and bisphenol A (BPA) value in placenta from pregnant women living in polluted area and pregnant women
living in a non-polluted area. a The expression of mir-146a was studied in placenta from 40 pregnant women, undergoing therapeutic abortion
occurring in the second trimester of pregnancy for fetal malformations and from 40 pregnant women living in a non-polluted area by microRNA
assay-based quantitative RT-PCR following the Delta-Delta Ct method. RNU6B was utilized for an endogenous reference to standardize microRNA
expression levels. The results were expressed as relative expression levels after calibration with the universal reference data. The asterisk indicates
a significant difference between patients with control group. P < 0.05. b Placental bisphenol A (BPA) value between 40 pregnant women, undergoing
therapeutic abortion occurring in the second trimester of pregnancy for fetal malformations and from 40 pregnant women living in a non-polluted
area P < 0.05
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Endocrine system genes pathway included genes as TP53
regulating kinase and MED1, Mediator complex subunit 1,
which have been shown may interact with Androgen recep-
tor, Estrogen receptor alpha, and p53.
Another biological function describrd cardiovascu-
lar disease gene as ABL2, ABL2 and EDNRB. Beside,
target genes of differential expression miR-146a were
enriched in several cancer-related pathways, includ-
ing the ErbB, p53, Toll and mTOR-like signalling
pathways. Their targets were significantly located in
cell plasma and organelles, enriched in metabolic
processes, transport and cell process pathways as
various regulators. Most of these target genes are in-
volved in signal transduction, transcription factor
Fig. 2 Correlation between total BPA level and relative has-miR-146a expression level in placenta from pregnant women living in polluted area.
A positive correlation between miR-146a and BPA expression levels was observed (Pearson’s correlation coefficient = 0.9789, P = 0.003)
Fig. 3 Gene networks regulated by miR-146a. Predicted miR-146a target genes identified by TargetScan and Miranda
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and cell differentiation. For example, it was found
that 24 target genes are involved in a wide range of
cellular responses including growth, survival, prolif-
eration, cell cycle, DNA repair, apoptosis.
The above insights provide a blueprint for the pathways
corresponding to a small fraction of somatic alterations due
to BPA exposure. In addition, the cross-talk between vari-
ous signalling pathways further complicated the pathway-
based analysis. Thus, this study may have to shift toward an
integrative network-based approach that accounts for more
extensive genomic alteration.
Discussion
This is the first in vivo report of miRNA expression in pla-
centa after BPA exposure, which has been examined in a
population of pregnant women undergo a therapeutic
abortion occurring in the second trimester of pregnancy
than has ever been reported.
Therefore, the aim of this study was to identify changes
in placenta miRNA expression impacted by gestational ex-
posure to BPA and to gain a comprehensive understanding
of developmental changes in the placenta transcriptome;
beside, to determine the impact of gestational exposure to
an environmentally relevant dose of BPA on fetuses
malformations.
Exposure to BPA at concentrations detected in humans
has been reported to affect neurological, cardiovascular
and metabolic diseases (such as diabetes), and even
cancers [2, 9].
Known the unique weakness of pregnant women and
their fetuses and the fact that this chemical can be endo-
crine disruptor, it is important to examine the level of
exposure in such population. It is critical to have bio-
monitoring data on a large diverse population of pregnant
women, since the health concerns of prenatal exposure to
BPA on the developing newborn and the physiological and
behavioural changes during pregnancy that can affect
exposure to and disposition of chemicals in the body [26].
We chose to examine a population of pregnant women
undergo a therapeutic abortion occurring in the second
trimester of pregnancy, living in a polluted area of southern
Italy and we found a correlation between the placenta BPA
level, miR-146a over expression in all placenta from women
bearing fetal malformations.
Here, we found that miR-146 expression was increased in
placenta from pregnant women, living in a high polluted
area, compared with women with a healthy pregnancy;
miR-146a expression in patients was positively associated
with the BPA level measured in placenta from the same
patient group. We have already analyzed (data not shown),
miR-146a expression in placenta from pregnant women,
living in a non-polluted area, subjected to therapeutic abor-
tion occurring in the second trimester of pregnancy, since
the fetuses had malformations. In placenta from such
women, miR-146 expression values resembled the level
detected in women with a healthy pregnancy. On the other
hand, pregnant women living in a polluted area with nor-
mal fetuses showed placental miR-146a expression values
similar to pregnant women living in a polluted area with
malformed fetuses (data not shown).
Environmental chemicals, such as bisphenol. A, can have
an epigenetic effects on DNA methylation, histone modifi-
cation, and expression of non-coding RNAs (including
microRNAs) of (BPA). Such finding has expanded our
understanding of the etiology of human complex diseases
such as cancers and diabetes. Epigenetics is an important
mechanism in the capability of environmental chemicals to
influence health and disease, and BPA, is epigenetically
toxic. Several data from in vitro and in vivo models have
established that epigenetic modifications caused by in utero
exposure to environmental toxicants can induce modifica-
tions in gene expression that may persist throughout life.
Male offspring rats exposed to DBP/BBP/MBP show
phenotypic alterations observed in during the perinatal
period which had noteworthy similarities with common
human reproductive disorders, including cryptorchidism,
hypospadias and low sperm counts [24]. Mixtures and
bisphenol A display additive interactions showing anti-
androgenic activities [25].
Exposure to low doses of bisphenol A (BPA) during
in utero and neonatal stage may cause DNA hypermethy-
lation/hypomethylation at CpG islands near gene
promoter regions, histone modifications (acetylation,
methylation, phosphorylation, ubiquitination, sumoylation
and ADP ribosylation), and altered expression of non-
coding RNAs, as microRNAs. These epigenetic changes
can bring to up/down alterations in gene expression persist
throughout all the life. In turn, such permanent changes
will result in adverse health effects such as neural and
immune disorders, infertility, and late-onset complex
diseases (cancers and diabetes). It has been reported that
the transient exposure to BPA of gestating female rats
produce differential DNA methylation to the F3 generation.
It has been shown that BPA exposure of human placental
cell lines alter miRNA expression levels, and in particular,
miR-146a was strongly induced. This resulted in both
slower proliferation rate and higher sensitivity to the DNA
damaging agent bleomycin [27]. Beside, mouse sertoli cell
line TM4 exposed to BPA for 24 h was reported to have
two-fold up or down-regulated 37 miRNAs [28].
The discovery that gestational BPA exposure has an effect
to increase the expression of most miRNAs within placenta
suggests that BPA may impact the processing machinery of
miRNAs. Previously, has been demonstrated hormonal
regulation of miRNA biogenesis enzymes by steroids, such
as estradiol (68). BPA could affect the miRNA biosynthetic
pathway by modulating the protein expression or the
protein activity of multiple components: beside these
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particular miRNA genes may have estrogens’ response
elements within their promoters, potential target for BPA.
The chance that mir-146a might modulate mRNA levels
and subsequent toxicity by BPA has not been explored
yet. MiRanda and TargetScan identified 123 conserved
genes that are potential targets of the miRNA evaluated in
our study.
Using the KEGG pathway database, we identified several
pathways that are involved in immune/inflammatory, can-
cer and neural diseases (Table 3). Figure 3 shows a sum-
mary of annotations and analysis of pathways for target
genes of miR-146a.
Although the molecular events underlying the effects of
developmental BPA exposure in humans remain unclear,
they appear to involve pathways beyond classical Estrogen
Receptor signalling. The identification of neural diseases
pathway was one among the significant biological functions
predicted for miR-146a gene targets. Notably, all of the 12
genes comprising this function, exhibited roles in impaired
nervous system functioning such as GRID1, which mediate
most of the fast excitatory synaptic transmission in the
central nervous system, play key roles in synaptic plasticity
and increased risk of developing schizophrenia. ROBO1,
implicated in communication disorder as dyslexia and com-
munication disease. SORT1, which is the key contributors
to aneurysmal disease. Mir-146a potentially interacts with
genes which are involved in cardiovascular diseases too as
ABL2, that mediate vascular permeability, and EDNRB
gene providing instructions for making a protein called
endothelin receptor type B. Endothelins regulate several
critical biological processes, including the development and
function of blood vessels, Regarding Endocrine system
regulation, in particular, hsa-mir-146a has complementary
sequence for 3′-UTR region of endocrine system genes as
MED1, which has been shown may interact with Androgen
receptor, Estrogen receptor alpha, and p53. The main
function of the androgen receptor is as a DNA-binding
transcription factor that regulates gene expression; how-
ever, the androgen receptor has other functions as well.
Androgen regulated genes are critical for the development
and maintenance of the male sexual phenotype. The estro-
gen receptor (ESR) is a ligand-activated transcription factor
composed of several domains important for hormone
binding, DNA binding, and activation of transcription.
TP53RK gene, encoding TP53-regulating kinase is a miR-
146a target. Distinct stresses, including ionising radiation,
virus infection and metabolic stress in the form of altered
AMP/ATP ratios, can induce p53 phosphorylation.
Nishizawa et al. [29, 30] found that placental gene expres-
sion after BPA exposure were studied in experiments that
focused on retinoic acid (RA) receptors (RAR and RXR)
and aryl hydrocarbon receptors (AhR). RA acts by binding
to RA receptors RAR and RXR, which dimerize to form
transcription factors. In a series of papers, Nishizawa et al.
advanced the hypothesis that BPA can activate AhR expres-
sion in embryos, thus subsequently altering RA action dur-
ing embryogenesis. BPA was administered orally during
organogenesis to mice and embryos were collected for the
analysis of mRNA expression by RT-PCR. In further sup-
port of AhR activation, expression of two other genes in
this pathway was also increased. CYP1A1 and GST (two
enzymes regulated by AhR) mRNA and protein expression
were increased at the higher doses of BPA and with E2.
The ability of BPA to alter miRNA expression in the
placenta might reflect a mechanism of BPA toxicity which
may bring harmful consequences for the developing fetus.
In the placenta, normal miRNA regulation in placental
tissue is extremely important due to growth-promoting and
the growth-inhibiting roles of human miRNAs.
Conclusions
In the environment the enhancing presence of BPA point
to look for a comprehensive examination of human
responses to BPA exposure, including molecular effects.
The significance of studying BPA’s consequences on the
placenta is accentuated by BPA’s tendency to accumulate in
such tissue and the general importance of placenta in fetal
development.
In summary, our findings suggest that BPA are able to
modify miRNAs expression in humans. In particular, mir-
146a is correlated significantly with BPA accumulation in
the placenta and may be the candidates to serve as promis-
ing biomarkers with sufficient sensitivity and specificity for
the diagnosis of BPA contamination.
However, the molecular mechanism through which mir-
146a might modulate mRNA levels and subsequent toxicity
by BPA has not been fully explored. This research serves as
a launching point for future studies.
Molecular mechanisms that underlie the long-lasting
effects of BPA and phthalates continue to be elucidated,
and they likely involve disruption of epigenetic program-
ming of gene expression during development. It will be
important to determine whether epigenetic markers in
more accessible tissues correlate with epigenetic markers in
target tissues. Many studies strongly imply that exposures
to endocrine-disrupting chemicals may have cumulative
adverse effects on future generations, and that these effects
could be mediated through epigenetic mechanisms.
Our research provides to demonstrate the utility of
miRNA expression profiles to improve our understanding
of environmental toxicants action and may support preven-
tion, diagnosis, and treatment of exposure-related effects.
Methods
Ethics statement
We obtained ethics approval for our study from the ethics
committee (also known as an Institutional Review Board)
at University of Salerno. All the participants had the
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Table 3 Genes and genomes pathway analysis of miR-146a target genes
Pathway Gene Symbol Gene Name
Apoptosis IRAK1 interleukin-1 receptor-associated
kinase 1,
Cancer APPL1 adaptor protein, phosphotyrosine interaction,
PH domain and leucine zipper containing 1;
SLC22A3 solute carrier family 22 (extraneuronal
monoamine transporter), member 3;
ERBB4 v-erb-a erythroblastic leukemia viral
oncogene homolog 4 (avian);
NOTCH1 notch 1;
SMAD4 SMAD family member 4;
CSF1R colony stimulating factor 1 receptor;
DOT1L DOT1-like, histone H3 methyltransferase (S. cerevisiae);
PTGFRN prostaglandin F2 receptor negative regulator;
IGF2BP1 insulin-like growth factor 2 mRNA binding protein 1;
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein);
RAD1 RAD1 homolog (S. pombe);
HIC2 hypermethylated in cancer 2;
MLL2 myeloid/lymphoid or mixed-lineage leukemia 2;
EDNRB endothelin receptor type B;
NOVA1 neuro-oncological ventral antigen 1;
ABL2 v-abl Abelson murine leukemia viral oncogene
homolog 2
Mapk pathway TRAF6 TNF receptor-associated factor 6
Cell differentation NOTCH1 notch 1;
SRP14 signal recognition particle 14 kDa (homologous
Alu RNA binding protein);
PSMD3 proteasome (prosome, macropain)
26S subunit, non-ATPase, 3;
GDNF glial cell derived neurotrophic factor;
SMAD4 SMAD family member 4;
SEMA3G sema domain, immunoglobulin domain
(Ig), short basic domain, secreted, (semaphorin) 3G;
MED1 mediator complex subunit 1;
LIPA lipase A, lysosomal acid, cholesterol esterase;
ROBO1 roundabout, axon guidance receptor,
homolog 1 (Drosophila);
Metabolic pathway SLC22A3 solute carrier family 22 (extraneuronal
monoamine transporter), member 3;
PGP phosphoglycolate phosphatase;
LIPA lipase A, lysosomal acid, cholesterol esterase;
DLST dihydrolipoamide S-succinyltransferase (E2
component of 2-oxo-glutarate complex);
DOT1L DOT1-like, histone H3 methyltransferase
(S. cerevisiae);
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein;
DGKG diacylglycerol kinase, gamma 90 kDa;
Neural disease IRAK1 interleukin-1 receptor-associated kinase 1;
MYT1 myelin transcription factor 1;
De Felice et al. BMC Medical Genomics  (2015) 8:56 Page 8 of 13
Table 3 Genes and genomes pathway analysis of miR-146a target genes (Continued)
ROBO1 roundabout, axon guidance receptor, homolog 1
(Drosophila);
LRRTM2 leucine rich repeat transmembrane neuronal 2;
GRID1 glutamate receptor, ionotropic, delta 1;
SORT1 sortilin 1;
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein);
SYT1 synaptotagmin I;
NPAS4 neuronal PAS domain protein 4;
MLL2 myeloid/lymphoid or mixed-lineage leukemia 2;
DNAL1 dynein, axonemal, light chain 1;
EDNRB endothelin receptor type B;
Binding protein NOVA1 neuro-oncological ventral antigen 1;
HNRNPD heterogeneous nuclear ribonucleoprotein D
Signal trasduction ABL2 v-abl Abelson murine leukemia viral oncogene
homolog 2;
NUMB numb homolog (Drosophila);
CNTFR ciliary neurotrophic factor receptor;
SRP14 signal recognition particle 14 kDa (homologous
Alu RNA binding protein);
GDNF glial cell derived neurotrophic factor;
SMAD4 SMAD family member 4;
KCTD15 potassium channel tetramerisation
domain containing 15;
NF2 neurofibromin 2 (merlin);
KLF4 Kruppel-like factor 4 (gut);
SCN3B sodium channel, voltage-gated, type III, beta;
NLGN1 neuroligin 1;
RIMS2 regulating synaptic membrane exocytosis 2;
Cardiovascular disease ABL2 v-abl Abelson murine leukemia viral oncogene
homolog 2;
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2;
EDNRB endothelin receptor type B;
Ubiquitin pathway DCAF12 DDB1 and CUL4 associated factor 12;
FBXW2 F-box and WD repeat domain containing 2;
WWP2 WW domain containing E3 ubiquitin protein ligase 2;
DTL denticleless homolog (Drosophila);
Trasport protein SLC10A3 solute carrier family 10 (sodium/bile acid
cotransporter family), member 3;
ERBB4 v-erb-a erythroblastic leukemia viral oncogene
homolog 4 (avian);
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2;
SH3GL2 SH3-domain GRB2-like 2;
SLCO3A1 solute carrier organic anion transporter family,
member 3A1;
GOSR1 golgi SNAP receptor complex member 1;
SLC39A1 solute carrier family 39 (zinc transporter),
member 1;
SORT1 sortilin 1;
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capacity to consent and we obtained written informed
consent from all participants involved in the study. Beside,
ethics approval for our study was obtained from the ethics
committee (also known as an Institutional Review Board)
at our institution.
Tissue collection
Eighty (40 patients and 40 controls) pregnant women,
were enrolled in a case–control study at the Department
of Medicine, of the “University of Salerno”. 40 pregnant
women living in a non-polluted area (control group:
Table 3 Genes and genomes pathway analysis of miR-146a target genes (Continued)
BTG2 BTG family, member 2;
Enzyme ERBB4 v-erb-a erythroblastic leukemia viral oncogene
homolog 4 (avian);
ADARB1 adenosine deaminase, RNA-specific, B1;
USP3 ubiquitin specific peptidase 3;
KDM2B lysine (K)-specific demethylase 2B;
SIAH2 seven in absentia homolog 2 (Drosophila);
CASK calcium/calmodulin-dependent serine
protein kinase (MAGUK family);
LIPA lipase A, lysosomal acid, cholesterol esterase;
CNOT6L
TRDMT1 CCR4-NOT transcription complex, subunit 6-like;
MPPE1 tRNA aspartic acid methyltransferase 1;
DCP1A DCP1 decapping enzyme homolog A
(S. cerevisiae);
DLGAP2 discs, large (Drosophila) homolog-associated
protein 2;
Kinase protein associated TRAF6 TNF receptor-associated factor 6;
PCDH1 protocadherin 1;
Prion disease NOTCH1 notch 1
Infection disease APPL1 adaptor protein, phosphotyrosine interaction,
PH domain and leucine zipper containing 1;
PGP phosphoglycolate phosphatase;
PSMD3 proteasome (prosome, macropain) 26S subunit,
non-ATPase, 3;
SMAD4 SMAD family member 4;
TAF9B TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31 kDa;
CD28 CD28 molecule;
WASF2 WAS protein family, member 2;
SRSF7 serine/arginine-rich splicing factor 7;
Trascriptor factor MAFF v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian);
CSF1R colony stimulating factor 1 receptor;
TAF9B TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor;
EIF5A2 eukaryotic translation initiation factor 5A2;
KLF4 Kruppel-like factor 4 (gut);
SP8 Sp8 transcription factor;
SOX5 SRY (sex determining region Y)-box 5;
Endocrine system MED1 mediator complex subunit 1;
TP53RK TP53 regulating kinase;
Cellular antigen CD84 CD84 molecule
Mirna survelliance PPP2R3A protein phosphatase 2, regulatory subunit B’, alpha;
RIMS2 regulating synaptic membrane exocytosis 2;
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women with a healthy pregnancy,) and 40 pregnant
women living in a polluted area (patient group: pregnant
women whose fetuses had malformations) from Salerno’
district (Italy), subjected to therapeutic abortion occur-
ring in the second trimester of pregnancy for fetal mal-
formation. Collection was done from June 2013 to July
2014. Additional maternal and infant data were collected
from medical records.
All patients met the inclusion criteria: 18–45 years of age,
residence in Salerno’ area in the past 5 years, null-parity/no
breastfeeding history, absence of immunologic, hormonal
disorders, or chronic diseases, and no occupational expos-
ure to BPA s or pesticides.
Sample selection was based on maternal arrival time
and time of placental delivery. Placentas were collected
from singleton births from HIV and hepatitis negative
mothers over 18 years of age. Whole placentas were
placed in Whirlpacs® (Nasco) and stored at 80 °C until
processing. Prior to analysis, the chorionic plate and
decidua basalis were removed with ceramic scissors, leav-
ing the villous core tissue to be homogenized. Samples
were oven dried at 60 °C and stored in 50 mL digestion
vessels (Environmental Express) at ambient temperature
until required for analysis.
GC-MS analysis
Placental BPA concentrations were determined by GC-MS
utilizing a double blind experiment design. Dried and
homogenized placental samples (50 mg) were transferred
into 2 mL Eppendorf™ vials and 0.5 mL H2O and 1.0 mL
of ethyl acetate (Romil, Cambridge, England) containing
the internal standard d16-BPA (deuterated Bisphenol A)
(ISOTEC; Aldrich, Taufkirchen, Germany) were added.
The vials were placed in a 60 °C ultrasonic water bath and
sonicated for 30 min. Then 500 mL of the supernatant
were transferred to 2 mL glass reaction vials, and the
extracts were evaporated to dryness under a stream of
nitrogen. Then 50 mL of the derivatizing reagent N,
O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) (Supelco,
Sigma, Germany) was added. The vials were sealed with
Teflon/silicone cap liners and heated in an oven (70 °C) for
2 h. The 2 mL glass vials were removed and 50 mL ethyl
acetate were added. Samples of 1 mL from this solution
were injected into the GC-MS system (GC-2010 Plus gas
chromatograph coupled to a 2010 Plus single quadrupole
mass spectrometer; Shimadzu Corp., Kyoto, Japan).
Chromatographic separation was achieved with a 60m_
0.25mmZB-5 ms fused silica capillary column with
0.25 mm film thickness from Phenomenex (Torrance, CA,
USA) with helium as carrier gas. The initial oven
temperature of 200 °C was held for 3 min and then raised
at 20 °C/min to 300 °C. The gas flow was set to achieve a
constant linear velocity of 40 cm/s and the split flow was
set to 1:10. The mass spectrometer was operated in
electron impact (70 eV) mode coupled with selected-ion
monitoring. All calibration curves displayed excellent lin-
earity (R2 ¼ 0.9998) over the range of BPA concentrations
from 1 to 70 ng/mL. Additional control experiments were
performed to ensure that BPA was not leached from the
GC-MS itself as well as storage containers and all the tubes
and vessels used to collect tissue from patients.
Statistics
Correlations between placental BPA concentrations and
miR-146a were analyzed with a Spearman’s Rank Correl-
ation. Alpha (a) was equal to 0.05.
RNA isolation
Placenta was collected during the second trimester of preg-
nancy from all women enrolled. Total RNA was extracted
using the TRizol reagent (Invitrogen Carlsbad, CA).
MicroRNA microarray
Placental microRNA profiles were generated using Human
miRNA Microarray kit, 8 × 60 K (based on miRBase release
16.0, Agilent Technologies). The miRNA Complete Label-
ing and Hyb Kit (Agilent Technologies) was used to label
and hybridize 100 ng of total RNA, according to the manu-
facturer’s instructions. Briefly, RNA samples were dephos-
phorylated and labeled with cyanine 3-pCp by T4 RNA
ligase for 2 h at 16 °C. RNA samples were hybridized to the
miRNA microarrays for 20 h at 55° in a hybridization oven
at 20 rpm. After washing, the slides were scanned by an
Agilent Microarray Scanner (Agilent Technologies). The
raw intensity of the array was scanned and extracted by
BeadScan, and the data were corrected by background sub-
traction in the Genome Studio module.
MicroRNA microarray data analysis
Expression data were extracted from the scanned images
using Feature Extraction software, version 10.7 (Agilent
Technologies) and analyzed with the R statistical environ-
ment (version 2.15.1). The background was adjusted by
subtracting the median background values from the median
expression values obtained by the Feature Extraction soft-
ware, followed by log base 2 transformations. The data were
quartile normalized by the GeneSpring Gx 12.6.1 software.
To calculate sample correlation, a Pearson uncentred
correlation was performed with the R package. miRNAs
expression levels were considered statistically significant
if the difference between the patients and control groups
was at least 2.5 fold (P-value < 0.05 and percentage of
false prediction (pfp) </= 5 %). To obtain a single expres-
sion value for each probe set, the median expression
value was calculated for multiple probe sets correspond-
ing to a unique miRNA.
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Real-time qPC for miRNA quantification
To quantify miRNA expression levels, microRNA assay-
based quantitative RT-PCR (qRT-PCR) was performed for
the mature miRNAs, using miScript PCR Starter Kit
(Quiagen). Real-time PCR was performed using a 7500
Fast Real-Time PCR system (Applied Biosystems, Foster
City, CA, USA), following the Δ-ΔCt method. RNU6B
was utilized for an endogenous reference to standardize
miRNA expression levels. All RT reactions were run in
triplicate. All the data were calibrated by the universal ref-
erence data. All results shown are mean +/− SD of at least
three separate experiments, measuring each parameter by
triplicate (n = 3). Statistical significant differences were
tested by one way analysis of variance (ANOVA), and,
when the F value was significant, by Student-Newman-
Keul’ s test. P value less than 0.05 (*) was considered sta-
tistically significant.
Target prediction and pathway mining
We used the miRNA target prediction software miRanda
(www.microrna.org/) and target scan (www.targetscan.org/)
to predict the target genes of miR-146a total of 54 target
conserved genes were annotated.
Predicted targets of miR-146a were classified into
functional pathways using the Kyoto Encyclopedia of
Genes and Genomes, KEGG (KEGG; www.genome.jp/
kegg/). A total of 54 KEGG pathways were annotated for
miR-146a.
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